Logo

Astellas Reports the US FDA Listing of DIGITIVA to Manage Heart Failure

Share this
Astellas

Astellas Reports the US FDA Listing of DIGITIVA to Manage Heart Failure

Shots:

  • The US FDA has listed Astellas' non-invasive digital health solution, DIGITIVA, for heart failure management, enabling patients to monitor their health at home & promoting collaboration with HCPs
  • The DIGITIVA solution comprises of Eko Health’s CORE 500 Digital Stethoscope, a heart failure-specific smartphone app built on Welldoc's platform & a clinical review team for patient data assessment. The app also offers educational materials from the American Heart Association for patients
  • The clinical review team analyzes patient data such as heart failure-specific biomarkers, and alerts the patient's physician if intervention is needed, aiming to reduce acute decompensation events and re-hospitalizations

Ref: Astellas | Image: Astellas

Related News:- Astellas’ Padcev Plus Keytruda Receives the EC’s Approval to Treat Advanced Urothelial Cancer

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions